You are here: Geisinger Medical
Laboratories > Test
Catalog
Geisinger Medical Laboratories/Geisinger Proven Diagnostics Test Catalog
VALPROIC ACID LEVEL |
||
ORDERING INFORMATION: |
Geisinger Epic Procedure Code: LAB3230 Geisinger Epic ID: 14240 | |
SPECIMEN COLLECTION |
||
Specimen type: |
Plasma or serum | |
Preferred collection container: |
||
Specimen required: |
2 mL aliquot of plasma or serum; minimum 0.2 mL | |
Patient preparation: |
Collect just prior to next dose. | |
| SPECIMEN PROCESSING |
||
Specimen processing instructions: |
Allow serum to clot. Centrifuge to separate serum or plasma within 2 hours of collection. | |
Transport temperature: |
Refrigerated (preferred) or frozen. | |
Specimen stability: |
Room temperature: 2 days. Refrigerated: 1 week. Frozen: 4 weeks. | |
Rejection criteria: |
Stability limits exceeded. | |
TEST DETAILS |
||
Reference interval: |
50-100 mcg/mL | |
Critical values/courtesy alerts: |
Above 121 mcg/mL. | |
Additional information: |
Significant interference with this procedure may occur in patients with antibodies induced during treatment with mouse monoclonal antibodies. | |
CPT code(s): |
80164 | |
| Note: The billing party has sole responsibility for CPT coding. Any questions regarding coding should be directed to the payer being billed. The CPT codes provided by GML are based on AMA guidelines and are for informational purposes only. | ||
Methodology: |
Immunoassay |
|
Synonyms: |
Depakene, Depakote, VALP, Valproate
|
|
Clinical significance: |
Valproic acid is used as an anticonvulsant to treat certain types of seizures, to prevent migraine headaches, and to treat various psychiatric illnesses such as bipolar disorder and aggression. Drugs that compete for protein-binding sites with valproic acid can increase the concentration of valproic acid. Therapeutic drug monitoring is useful to optimize dose. Measurement of the free concentration is useful if toxicity is suspected. | |
Doctoral Director(s:) |
Hoi-Ying Elsie Yu, PhD, DABCC Sheng-Ying (Margaret) Lo, PhD, DABCC |
|
| Review Date: | 12/14/2022 | |